Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SNCA | P37840 | 7/20 | 0.53 |
| ▸ | APP | P05067 | 7/20 | 0.53 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.40 |
| ▸ | CNR1 | P21554 | 4/20 | 0.37 |
| ▸ | CNR2 | P34972 | 4/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | ELANE | P08246 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27440665 | 0.85 | SNCA (0.61) | SNCAAPPENPP2CNR1CNR2 | |
| SCHEMBL27440401 | 0.85 | APP (0.55) | SNCAAPPENPP2CNR1CNR2 | |
| SCHEMBL31050160 | 0.85 | APP (0.55) | SNCAAPPENPP2CNR1CNR2 | |
| SCHEMBL24163770 | 0.82 | SNCA (0.62) | SNCAAPPENPP2CNR1CNR2 | |
| SCHEMBL27440870 | 0.81 | APP (0.47) | SNCAAPPENPP2KDM4EALDH1A1 | |
| SCHEMBL24164716 | 0.81 | SNCA (0.57) | SNCAAPPENPP2CNR1CNR2 | |
| SCHEMBL27440479 | 0.79 | SNCA (0.53) | SNCAAPPENPP2CNR1CNR2 | |
| SCHEMBL28377102 | 0.78 | APP (0.57) | SNCAAPPENPP2CNR1CNR2 | |
| SCHEMBL20603144 | 0.78 | APP (0.57) | SNCAAPPENPP2CNR1CNR2 | |
| SCHEMBL20603150 | 0.78 | SNCA (0.53) | SNCAAPPENPP2CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024145369-A1 | COMPOUNDS FOR TREATMENT OF HAIR LOSS | PELAGE PHARMACEUTICALS, INC. (US) | 2024-07-04 | — | — | WO | disclosed |